Rifalazil
Catalog No.
BA1263
Rifalazil (ABI-1648; KRM-1648) is a rifamycin derivative.
Featured Products
Rifalazil (ABI-1648; KRM-1648) is a rifamycin derivative that kills bacterial-infected cells by inhibiting bacterial DNA-dependent RNA polymerase and by blocking the β subunit of RNA polymerase.Rifalazil (ABI-1648; KRM-1648) is an antibiotic that inhibits Mycobacterium avium, gram-positive bacteria Helicobacter pylori, Chlamydia pneumoniae and Chlamydia trachomatis with values ranging from 0.00025 to 0.0025 μg/ml.Rifalazil (ABI-1648; KRM-1648) has the potential to be used in studies related to chlamydial infections, clostridium-associated diarrheal bacterial infections (CDAD), and tuberculosis (TB) research.
| Physical Appearance | A solid |
| Storage | Tightly sealed and desiccated at 4°C |
| M.Wt | 941.07 |
| Cas No. | 129791-92-0 |
| Formula | C51H64N4O13 |
| Synonyms | KRM-1648;ABI-1648 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |